Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 1.01% is in line with its 5-year average of 0.94%, near the low end of its 5-year range (0.57%–3.04%).
As of the fiscal period ended Tuesday, June 30, 2026. 42.04% below its 12-month average of 1.75%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 1.01%.
DEBT TO ASSETS RATIO
1.01%
DEBT TO ASSETS RATIO AVG TTM
1.75%
DEBT TO ASSETS RATIO AVG 3Y
1.54%
DEBT TO ASSETS RATIO AVG 5Y
0.94%
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-42.04%
CURRENT VS 3Y AVG
-34.19%
CURRENT VS 5Y AVG
+8.42%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
+1026.85%
vs the sector median at left
LeonaBio, Inc.
Market Cap
$22.68M
Debt to Assets Ratio
1.01%
TTM Avg
1.75%
3Y Avg
1.54%
5Y Avg
0.94%
Market Cap
$23.06M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$22.25M
Debt to Assets Ratio
0.02%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$22.00M
Debt to Assets Ratio
0.17%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$23.38M
Debt to Assets Ratio
0.15%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$24.44M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| LeonaBio, Inc. (LONA) | $22.68M | 1.01% | 1.75% | 1.54% | 0.94% |
| Rein Therapeutics Inc. (RNTX)vs › | $23.06M | 0.00% | N/A | N/A | N/A |
| Modular Medical, Inc. (MODD)vs › | $22.25M | 0.02% | N/A | N/A | N/A |
| Aytu BioPharma, Inc. (AYTU)vs › | $22.00M | 0.17% | N/A | N/A | N/A |
| TherapeuticsMD, Inc. (TXMD)vs › | $23.38M | 0.15% | N/A | N/A | N/A |
| Kyntra Bio, Inc. (KYNB)vs › | $24.13M | 0.00% | N/A | N/A | N/A |
| Atossa Therapeutics, Inc. (ATOS)vs › | $24.44M | 0.00% | N/A | N/A | N/A |
| InspireMD, Inc. (NSPR)vs › | $24.60M | 0.04% | N/A | N/A | N/A |
| NextCure, Inc. (NXTC)vs › | $20.53M | 0.19% | N/A | N/A | N/A |
| ABVC BioPharma, Inc. (ABVC)vs › | $25.22M | 0.09% | N/A | N/A | N/A |
Debt/Assets
1.0%
Debt/Equity
0.02
Current Ratio
7.01
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 1.01% |
| 2026-03-31 | 0.97% |
| 2025-12-31 | 0.87% |
| 2025-09-30 | 3.04% |
| 2025-06-30 | 2.86% |
| 2025-03-31 | 2.57% |
| 2024-12-31 | 2.07% |
| 2024-09-30 | 1.52% |
| 2024-06-30 | 1.26% |
| 2024-03-31 | 1.12% |
| 2023-12-31 | 0.99% |
| 2023-09-30 | 0.91% |
| 2023-06-30 | 0.84% |
| 2023-03-31 | 0.79% |
| 2022-12-31 | 0.74% |
| 2022-09-30 | 0.73% |
| 2022-06-30 | 0.71% |
| 2022-03-31 | 0.59% |
| 2021-12-31 | 0.58% |
| 2021-09-30 | 0.57% |
| 2021-06-30 | 0.57% |
| 2021-03-31 | 0.51% |
| 2020-12-31 | 0.36% |
| 2020-09-30 | 0.36% |
| 2020-06-30 | 0.00% |
| 2019-12-31 | 70.95% |
